首页 > 市场调查报告书 > 製药

全球良性前列腺增生治疗市场研究报告 - 2023 年至 2030 年行业分析、规模、份额、增长、趋势和预测

市场调查报告书

商品编码

1342840

全球良性前列腺增生治疗市场研究报告 - 2023 年至 2030 年行业分析、规模、份额、增长、趋势和预测

Global Benign Prostatic Hyperplasia Treatment Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030

出版日期: 2023年08月01日 | 出版商:

Value Market Research | 英文 144 Pages | 商品交期: 最快1-2个工作天内

价格

简介目录图表

全球良性前列腺增生治疗市场需求预计将从 2022 年的 103.4 亿美元达到 2030 年的近 219.8 亿美元，2023-2030 年研究期间复合年增长率为 8.74%。

BPH 代表良性前列腺增生，是前列腺内的非癌细胞增殖。前列腺内部首先受到影响。由于前列腺肥大，尿道逐渐受到压缩。 BPH 药物、手术和微创手术是治疗 BPH 的可行药物。这些手术有助于减少异常的前列腺生长或放鬆膀胱平滑肌。

市场动态：

进步的主要驱动力是良性前列腺增生（BPH）的高发病率、对微创手术的日益偏好，以及用于开发创新疗法的赠款、投资和资金的增加。此外，前列腺增生症的发病率很大程度上受到人口老龄化的影响，尤其是老年男性群体，这推动了全球对药品的需求。良性前列腺增生前列腺治疗市场预计也将受益于肥胖、缺乏身体活动的增加以及人们对治疗良性前列腺增生药物的认识的提高。

该研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具还对全球良性前列腺增生治疗市场的各个细分市场进行了包容性评估。良性前列腺增生治疗行业的增长和趋势为本研究提供了整体方法。

区域分析：

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲良性前列腺增生治疗市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。良性前列腺增生治疗市场的主要参与者包括波士顿科学公司、泰利福公司、Endo International Plc、Urologix LLC、LISA Laser、奥林巴斯公司。本节包含竞争格局的整体视图，包括各种战略发展，例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。

如果您有任何定制要求，请写信给我们。我们的研究团队可以根据您的需求提供定制报告。

按治疗概述
历史和预测数据
按治疗分析
药物类别（α-阻滞剂、5-α-还原酶抑製剂 (5-ARIs)、磷酸二酯酶 5 酶抑製剂、其他）
微创手术（经尿道前列腺切除术（TURP）、经尿道前列腺切开术（TUIP）、机器人手术、经尿道微波热疗（TUMT）、前列腺尿道提升术等）
激光治疗
其他的

第 7 章：全球良性前列腺增生治疗市场分析：按最终用户分类

最终用户概述
历史和预测数据
最终用户分析
医院
门诊手术中心
专科诊所
其他的

第 8 章：全球良性前列腺增生治疗市场分析：按地理位置

区域展望
介绍
北美销售分析
- 概述、历史和预测销售分析
- 北美按细分市场销售分析
- 北美按国家/地区销售分析
- 美国销售分析
- 加拿大销售分析
- 墨西哥销售分析
欧洲销售分析
- 概述、历史和预测销售分析
- 欧洲按细分市场销售分析
- 欧洲按国家/地区销售分析
- 英国销售分析
- 法国销售分析
- 德国销售分析
- 意大利销售分析
- 俄罗斯销售分析
- 欧洲其他地区销售分析
亚太地区销售分析
- 概述、历史和预测销售分析
- 亚太地区按细分市场销售分析
- 亚太地区国家/地区销售分析
- 中国销售分析
- 印度销售分析
- 日本销售分析
- 韩国销售分析
- 澳大利亚销售分析
- 亚太地区其他地区销售分析
拉丁美洲销售分析
- 概述、历史和预测销售分析
- 拉丁美洲按细分市场销售分析
- 拉丁美洲按国家/地区销售分析
- 巴西销售分析
- 阿根廷销售分析
- 秘鲁销售分析
- 智利销售分析
- 拉丁美洲其他地区销售分析
中东和非洲销售分析
- 概述、历史和预测销售分析
- 中东和非洲按细分市场销售分析
- 中东和非洲国家销售分析
- 沙特阿拉伯销售分析
- 阿联酋销售分析
- 以色列销售分析
- 南非销售分析
- 中东其他地区和非洲销售分析

第 9 章：良性前列腺增生治疗公司的竞争格局

良性前列腺增生治疗市场竞争
伙伴关係/协作/协议
併购
新产品发布
其他发展

第 10 章：公司简介

顶级公司市场份额分析
市场集中度
Boston Scientific Corporation

公司简介
公司收入
产品
最近的发展

Teleflex Incorporated

公司简介
公司收入
产品
最近的发展

Endo International Plc

公司简介
公司收入
产品
最近的发展

Urologix LLC

公司简介
公司收入
产品
最近的发展

LISA Laser

公司简介
公司收入
产品
最近的发展

Olympus Corporation

公司简介
公司收入
产品
最近的发展

注意 - 在公司概况中，财务详细信息和近期发展视情况而定，或者如果是私营公司，则可能不包括在内

简介目录图表

Product Code: VMR11219538

The global demand for Benign Prostatic Hyperplasia Treatment Market is presumed to reach the market size of nearly USD 21.98 BN by 2030 from USD 10.34 BN in 2022 with a CAGR of 8.74% under the study period 2023 - 2030.

BPH stands for benign prostatic hyperplasia, which is a noncancerous cell proliferation inside the prostate gland. The inside of the prostate is first affected. The urethra then gradually becomes compressed as a result of prostatic enlargement. BPH medicines, surgery, and minimally invasive surgery are among viable medical treatments for BPH. These procedures aid in reducing the aberrant prostrate growth or relaxing the smooth bladder muscles.

MARKET DYNAMICS:

The main drivers of advancement are the high incidence of BPH, rising preference for minimally invasive procedures, and rising grants, investments, and funding for the development of innovative treatments. Furthermore, the incidence of BPH is greatly influenced by the ageing population, especially the senior male segment, which drives the demand for pharmaceuticals worldwide. The market for benign prostatic hyperplasia prostate treatment is also anticipated to benefit from the rise in obesity, physical inactivity, and increased awareness of the existence of drugs for treating benign prostatic hyperplasia.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of benign prostatic hyperplasia treatment. The growth and trends of benign prostatic hyperplasia treatment industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the benign prostatic hyperplasia treatment market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Treatment

Drug Class (Alpha-Blockers, 5-Alpha-Reductase Inhibitor (5-ARIs), Phosphodiesterase-5 Enzyme Inhibitor, Others)
Minimally Invasive Surgeries (Transurethral Resection Of The Prostate (TURP), Transurethral Incision Of The Prostate (TUIP), Robotic Surgeries, Transurethral Microwave Thermotherapy (TUMT), Prostatic Urethral Lift, Others)
Laser Therapy
Others

By End-User

Hospitals
Ambulatory Surgical Centers
Specialty Clinics
Others

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the Benign Prostatic Hyperplasia Treatment market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the benign prostatic hyperplasia treatment market include Boston Scientific Corporation, Teleflex Incorporated, Endo International Plc, Urologix LLC, LISA Laser, Olympus Corporation. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1 . PREFACE

1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3 . BENIGN PROSTATIC HYPERPLASIA TREATMENT - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Treatment
- 3.7.2 Market Attractiveness Analysis By End-user
- 3.7.3 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

6 . GLOBAL BENIGN PROSTATIC HYPERPLASIA TREATMENT MARKET ANALYSIS BY TREATMENT

6.1 Overview by Treatment
6.2 Historical and Forecast Data
6.3 Analysis by Treatment
6.4 Drug Class (Alpha-blockers, 5-Alpha-reductase Inhibitor (5-ARIs), Phosphodiesterase-5 Enzyme Inhibitor, Others) Historic and Forecast Sales by Regions
6.5 Minimally Invasive Surgeries (Transurethral Resection of the Prostate (TURP), Transurethral Incision of the Prostate (TUIP), Robotic Surgeries, Transurethral Microwave Thermotherapy (TUMT), Prostatic Urethral Lift, Others) Historic and Forecast Sales by Regions
6.6 Laser Therapy Historic and Forecast Sales by Regions
6.7 Others Historic and Forecast Sales by Regions

7 . GLOBAL BENIGN PROSTATIC HYPERPLASIA TREATMENT MARKET ANALYSIS BY END-USER

7.1 Overview by End-user
7.2 Historical and Forecast Data
7.3 Analysis by End-user
7.4 Hospitals Historic and Forecast Sales by Regions
7.5 Ambulatory Surgical Centers Historic and Forecast Sales by Regions
7.6 Specialty Clinics Historic and Forecast Sales by Regions
7.7 Others Historic and Forecast Sales by Regions

8 . GLOBAL BENIGN PROSTATIC HYPERPLASIA TREATMENT MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1. Overview, Historic and Forecast Sales Analysis
- 8.3.2. North America By Segment Sales Analysis
- 8.3.3. North America By Country Sales Analysis
- 8.3.4. United State Sales Analysis
- 8.3.5. Canada Sales Analysis
- 8.3.6. Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1. Overview, Historic and Forecast Sales Analysis
- 8.4.2. Europe by Segment Sales Analysis
- 8.4.3. Europe by Country Sales Analysis
- 8.4.4. United Kingdom Sales Analysis
- 8.4.5. France Sales Analysis
- 8.4.6. Germany Sales Analysis
- 8.4.7. Italy Sales Analysis
- 8.4.8. Russia Sales Analysis
- 8.4.9. Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1. Overview, Historic and Forecast Sales Analysis
- 8.5.2. Asia Pacific by Segment Sales Analysis
- 8.5.3. Asia Pacific by Country Sales Analysis
- 8.5.4. China Sales Analysis
- 8.5.5. India Sales Analysis
- 8.5.6. Japan Sales Analysis
- 8.5.7. South Korea Sales Analysis
- 8.5.8. Australia Sales Analysis
- 8.5.9. Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1. Overview, Historic and Forecast Sales Analysis
- 8.6.2. Latin America by Segment Sales Analysis
- 8.6.3. Latin America by Country Sales Analysis
- 8.6.4. Brazil Sales Analysis
- 8.6.5. Argentina Sales Analysis
- 8.6.6. Peru Sales Analysis
- 8.6.7. Chile Sales Analysis
- 8.6.8. Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1. Overview, Historic and Forecast Sales Analysis
- 8.7.2. Middle East & Africa by Segment Sales Analysis
- 8.7.3. Middle East & Africa by Country Sales Analysis
- 8.7.4. Saudi Arabia Sales Analysis
- 8.7.5. UAE Sales Analysis
- 8.7.6. Israel Sales Analysis
- 8.7.7. South Africa Sales Analysis
- 8.7.8. Rest Of Middle East And Africa Sales Analysis

9 . COMPETITIVE LANDSCAPE OF THE BENIGN PROSTATIC HYPERPLASIA TREATMENT COMPANIES

9.1. Benign Prostatic Hyperplasia Treatment Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10 . COMPANY PROFILES OF BENIGN PROSTATIC HYPERPLASIA TREATMENT INDUSTRY

10.1. Top Companies Market Share Analysis
10.2. Market Concentration Rate
10.3. Boston Scientific Corporation
- 10.3.1. Company Overview
- 10.3.2. Company Revenue
- 10.3.3. Products
- 10.3.4. Recent Developments
10.4. Teleflex Incorporated
- 10.4.1. Company Overview
- 10.4.2. Company Revenue
- 10.4.3. Products
- 10.4.4. Recent Developments
10.5. Endo International Plc
- 10.5.1. Company Overview
- 10.5.2. Company Revenue
- 10.5.3. Products
- 10.5.4. Recent Developments
10.6. Urologix LLC
- 10.6.1. Company Overview
- 10.6.2. Company Revenue
- 10.6.3. Products
- 10.6.4. Recent Developments
10.7. LISA Laser
- 10.7.1. Company Overview
- 10.7.2. Company Revenue
- 10.7.3. Products
- 10.7.4. Recent Developments
10.8. Olympus Corporation
- 10.8.1. Company Overview
- 10.8.2. Company Revenue
- 10.8.3. Products
- 10.8.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

简介目录图表

LIST OF TABLES

Market Snapshot
Drivers : Impact Analysis
Restraints : Impact Analysis
List of Raw Material
List of Raw Material Manufactures
List of Potential Buyers
Analysis by Treatment (USD MN)
Drug Class (Alpha-blockers, 5-Alpha-reductase Inhibitor (5-ARIs), Phosphodiesterase-5 Enzyme Inhibitor, Others) Market Sales by Geography (USD MN)
Minimally Invasive Surgeries (Transurethral Resection of the Prostate (TURP), Transurethral Incision of the Prostate (TUIP), Robotic Surgeries, Transurethral Microwave Thermotherapy (TUMT), Prostatic Urethral Lift, Others) Market Sales by Geography (USD MN)
Laser Therapy Market Sales by Geography (USD MN)
Others Market Sales by Geography (USD MN)
Analysis Market by End-user (USD MN)
Hospitals Market Sales by Geography (USD MN)
Ambulatory Surgical Centers Market Sales by Geography (USD MN)
Specialty Clinics Market Sales by Geography (USD MN)
Others Market Sales by Geography (USD MN)
Global Benign Prostatic Hyperplasia Treatment Market Sales by Geography (USD MN)
North America Market Analysis (USD MN)
United State Market Analysis (USD MN)
Canada Market Analysis (USD MN)
Mexico Market Analysis (USD MN)
Europe Market Analysis (USD MN)
Europe Market Estimate by Country (USD MN)
United Kingdom Market Analysis (USD MN)
France Market Analysis (USD MN)
Germany Market Analysis (USD MN)
Italy Market Analysis (USD MN)
Russia Market Analysis (USD MN)
Spain Market Analysis (USD MN)
Rest of Europe Market Analysis (USD MN)
Asia Pacific Market Analysis (USD MN)
China Market Analysis (USD MN)
Japan Market Analysis (USD MN)
India Market Analysis (USD MN)
South Korea Market Analysis (USD MN)
Australia Market Analysis (USD MN)
Rest of Asia Pacific Market Analysis (USD MN)
Latin America Market Analysis (USD MN)
Brazil Market Analysis (USD MN)
Argentina Market Analysis (USD MN)
Peru Market Analysis (USD MN)
Chile Market Analysis (USD MN)
Rest of Latin America Market Analysis (USD MN)
Middle East & Africa Market Analysis (USD MN)
Saudi Arabia Market Analysis (USD MN)
UAE Market Analysis (USD MN)
Israel Market Analysis (USD MN)
South Africa Market Analysis (USD MN)
Rest of Middle East and Africa Market Analysis (USD MN)
Partnership/Collaboration/Agreement
Mergers And Acquisition

LIST OF FIGURES

Research Scope of Benign Prostatic Hyperplasia Treatment Report
Market Research Process
Market Research Methodology
Global Benign Prostatic Hyperplasia Treatment Market Size, by Region (USD MN)
Porters Five Forces Analysis
Market Attractiveness Analysis by Treatment
Market Attractiveness Analysis by End-user
Market Attractiveness Analysis by Region
Value Chain Analysis
Global Market Analysis by Treatment (USD MN)
Drug Class (Alpha-blockers, 5-Alpha-reductase Inhibitor (5-ARIs), Phosphodiesterase-5 Enzyme Inhibitor, Others) Market Sales by Geography (USD MN)
Minimally Invasive Surgeries (Transurethral Resection of the Prostate (TURP), Transurethral Incision of the Prostate (TUIP), Robotic Surgeries, Transurethral Microwave Thermotherapy (TUMT), Prostatic Urethral Lift, Others) Market Sales by Geography (USD MN)
Laser Therapy Market Sales by Geography (USD MN)
Others Market Sales by Geography (USD MN)
Global Market Analysis by End-user (USD MN)
Hospitals Market Sales by Geography (USD MN)
Ambulatory Surgical Centers Market Sales by Geography (USD MN)
Specialty Clinics Market Sales by Geography (USD MN)
Others Market Sales by Geography (USD MN)
Global Market by Revenue
North America Market by Revenue
Europe Market by Revenue
Asia Pacific Market by Revenue
Latin America Market by Revenue
Middle East & Africa Market by Revenue
Recent Development in Industry
Top Companies Market Share Analysis